CINCINNATI, Jan. 31 /PRNewswire-FirstCall/ -- The Kroger Co. (NYSE: KR) said today it is recalling peanut butter store-baked and store-packaged cookies and select cakes sold in its family of stores because the products have the potential to be contaminated with Salmonella.
Stores under the following names in the 31 states where Kroger operates are included in this recall: Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, King Soopers, Smith's, Dillons, QFC, City Market, Foods Co., Jay C, Scott's, Owen's, Baker's, Gerbes, Hilander and Pay Less.
No illnesses have been reported in connection with the cookies and cakes.
Kroger is recalling all packages of the following Kroger, Store-Brand and Private Selection store-baked and store-packaged cookies:
- Peanut Butter Cookies - Regular, Jumbo, Decorated, Iced, Gourmet, Mini and Sandwich cookies
- Assorted and Variety Bakery Cookies - Regular and Jumbo
- Private Selection Peanut Chocolate Chunk Cookies
- Private Selection Gourmet Variety Cookie Trays
Kroger is recalling all sizes of the following Private Selection Cakes, including whole, half and packaged slices:
- Private Selection Chocolate Trio Single-Layer and Double-Layer Iced Cakes
Customers who have purchased any of the cookies or cakes listed above should not consume these products and should return them to a store for a full refund or replacement.
The products Kroger is recalling may be associated with the peanut product recall by Peanut Corporation of America (PCA). The FDA has indicated that PCA is the focus of its investigation into Salmonella-related illnesses that may be linked to contaminatedPage: 1 2 3 Related medicine technology :1
. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment2
. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment3
. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program4
. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target5
. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients6
. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management7
. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.8
. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation9
. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention10
. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union11
. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy